J84.114
Acute interstitial pneumonitis
Clinical Classification Guidelines
Inclusion Terms
- Hamman-Rich syndrome
Excludes Type 1
- pneumocystis pneumonia (B59)
Medical Intelligence & Overview
Acute interstitial pneumonitis, also known as Hamman-Rich syndrome, is a rare and serious lung condition characterized by rapid inflammation and scarring of the lung tissues. This disorder affects the interstitial space, which is the area surrounding the tiny air sacs (alveoli) where oxygen transfer occurs. The disease progresses quickly, leading to severe breathing difficulties and often requiring urgent medical attention. Although its exact cause remains unknown, recognizing the signs and understanding the nature of the condition can help facilitate prompt diagnosis and management.
Causes & Symptoms
Clinical Causes: The precise cause of acute interstitial pneumonitis is unknown. It may develop as an idiopathic condition, meaning no specific trigger is identified. Some cases occur following viral infections or exposure to certain environmental toxins. Rarely, it may be associated with autoimmune disorders or drug reactions. Genetic predispositions are suspected but not well-established.
Key Symptoms: Sudden onset of severe shortness of breath Rapid breathing (tachypnea) Persistent and dry cough High fever, often accompanied by chills Pleuritic chest pain or discomfort Fatigue and weakness Cyanosis (bluish discoloration of lips and fingertips) in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing acute interstitial pneumonitis involves a combination of clinical evaluation, imaging tests, and laboratory studies. Common diagnostic steps include: - **Medical history and physical examination:** Assessing symptom onset, duration, and potential exposures. - **Chest X-ray:** Typically shows bilateral lung infiltrates and diffuse lung involvement. - **High-resolution computed tomography (HRCT):** Offers detailed images revealing ground-glass opacities and interstitial changes. - **Pulmonary function tests:** May demonstrate restrictive lung patterns. - **Blood tests:** To check for infection, inflammation, and autoimmune markers. - **Bronchoscopy with lavage or biopsy:** In some cases, tissue samples help exclude other causes such as infections or malignancies. - **Exclusion of other conditions:** Such as pneumonia, connective tissue diseases, or drug-induced lung injury.
Treatment Protocols: Managing acute interstitial pneumonitis is challenging due to its rapid progression. Typically, the treatment approach includes: - **Corticosteroids:** High-dose steroids to reduce lung inflammation are often administered as the first line of therapy. - **Supportive care:** Including oxygen therapy and mechanical ventilation if necessary, to support breathing. - **Immunosuppressive medications:** Such as cyclophosphamide or azathioprine may be considered in some cases. - **Management of complications:** Addressing secondary infections or other issues arising from lung failure. - **Monitoring and follow-up:** Regular assessments to evaluate response to therapy and adjust treatment plans. - **Experimental therapies and clinical trials:** Might be explored in refractory cases, given the limited proven options.
Clinical Advice & FAQs
Billing Guidance
Is J84.114 a billable ICD-10 code?
Yes, J84.114 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J84.114?
Clinical documentation must specify the nature of Acute interstitial pneumonitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference